PLX - Protalix BioTherapeutics, Inc.

QQQ $ 440.80 $ 0.34 (0.08 %)

DIA $ 393.24 $ 3.06 (0.78 %)

SPY $ 519.21 $ 1.76 (0.34 %)

TLT $ 90.58 $ 0.54 (0.6 %)

GLD $ 216.10 $ 1.40 (0.65 %)

Previous Close

$ 1.14

Open

$ 1.13

Bid

$ 1.20 x 1,000

Ask

$ 0.00 x 0

Day's Range

$ 1.13 - $ 1.23

52 Week Range

$ 1.07 - $ 3.13

Volume

286,011

Average Volume

Market Cap

93.96M

Beta (5Y Monthly)

$ 0.99

PE Ratio (TTM)

$ 11.30

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-14-2024	12-31-2023	10-K
2	11-06-2023	09-30-2023	10-Q
3	08-07-2023	06-30-2023	10-Q
4	05-04-2023	03-31-2023	10-Q
5	02-27-2023	12-31-2022	10-K
6	11-14-2022	09-30-2022	10-Q
7	08-15-2022	06-30-2022	10-Q
8	05-16-2022	03-31-2022	10-Q
9	03-31-2022	12-31-2021	10-K
10	11-15-2021	09-30-2021	10-Q
11	08-16-2021	06-30-2021	10-Q
12	05-14-2021	03-31-2021	10-Q
13	03-30-2021	12-31-2020	10-K
14	10-29-2020	09-30-2020	10-Q
15	08-10-2020	06-30-2020	10-Q
16	06-01-2020	03-31-2020	10-Q
17	03-12-2020	12-31-2019	10-K
18	11-07-2019	09-30-2019	10-Q
19	08-08-2019	06-30-2019	10-Q
20	05-06-2019	03-31-2019	10-Q
21	03-18-2019	12-31-2018	10-K
22	11-07-2018	09-30-2018	10-Q
23	08-09-2018	06-30-2018	10-Q
24	05-09-2018	03-31-2018	10-Q
25	03-06-2018	12-31-2017	10-K
26	11-08-2017	09-30-2017	10-Q
27	08-09-2017	06-30-2017	10-Q
28	05-10-2017	03-31-2017	10-Q
29	03-16-2017	12-31-2016	10-K
30	11-09-2016	09-30-2016	10-Q
31	08-08-2016	06-30-2016	10-Q
32	05-09-2016	03-31-2016	10-Q
33	03-08-2016	12-31-2015	10-K
34	11-09-2015	09-30-2015	10-Q
35	08-10-2015	06-30-2015	10-Q
36	05-07-2015	03-31-2015	10-Q
37	03-12-2015	12-31-2014	10-K
38	11-10-2014	09-30-2014	10-Q
39	08-07-2014	06-30-2014	10-Q
40	05-08-2014	03-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Protalix BioTherapeutics Q4 GAAP EPS $(0.0...
03/14/2024 10:56:37

Protalix BioTherapeutics (AMEX:PLX) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate ...

Earnings Scheduled For March 14, 2024
03/14/2024 09:52:13

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.

Earnings Preview: Protalix BioTherapeutics
03/13/2024 19:01:56

HC Wainwright & Co. Reiterates Buy on Prot...
11/14/2023 11:50:25

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Protalix BioTherapeutics (AMEX:PLX) with a Buy and maintains $...

Earnings Scheduled For November 6, 2023
11/06/2023 13:24:53

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on ...

Protalix BioTherapeutics Q3 EPS $(0.04), I...
11/06/2023 11:51:58

Protalix BioTherapeutics (AMEX:PLX) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. Th...

Earnings Preview For Protalix BioTherapeutics
11/03/2023 21:01:02

HC Wainwright & Co. Maintains Buy on Prota...
10/31/2023 11:31:36

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Protalix BioTherapeutics (AMEX:PLX) with a Buy and raises the p...

protalix-biotherapeutics-and-2-other-penny-stocks-insiders-are-buying

Protalix BioTherapeutics And 2 Other Penny...
10/23/2023 12:55:38

The Dow Jones closed lower by around 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence...

Protalix BioTherapeutics Says Operations H...
10/09/2023 11:07:05

"Hostilities have not taken place where Protalix's facilities are located and we do not anticipate any disruption to th...

Protalix BioTherapeutics Appoints Eliot Ri...
09/12/2023 10:54:29

Zeev Bronfeld, the current Chairman of the Company's Board of Directors, will retire on the same day.

Watching Protalix BioTherapeutics; Zacks S...
08/08/2023 14:14:05

https://scr.zacks.com/files/News/2023/Zacks_SCR_Research_08082023_PLX_Vandermosten.pdf

12-health-care-stocks-moving-in-mondays-pre-market-session

12 Health Care Stocks Moving In Monday's P...
08/07/2023 13:05:51

Protalix BioTherapeutics Q2 EPS $0.21 Beat...
08/07/2023 10:55:09

Protalix BioTherapeutics (AMEX:PLX) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of...

Earnings Scheduled For August 7, 2023
08/07/2023 08:12:28

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report quarterly loss at $0.44 per share on revenu...

Preview: Protalix BioTherapeutics's Earnings
08/04/2023 20:01:35

Protalix BioTherapeutics To Join Russell 3...
05/23/2023 10:52:03

Protalix Biotherapeutics Is Eligible To Re...
05/18/2023 10:52:26

fabry-disease-treatment-showdown-protalix-bios-elfabrio-joins-the-ranks-of-sanofi-and-amicus-therapeutics

Fabry Disease Treatment Showdown: Protalix...
05/10/2023 18:16:01

The FDA approved Chiesi Group and Protalix BioTherapeutics Inc's (NASDAQ: PLX) Elfabrio (pegunigalsidase alfa-iwxj) for tre...

Chiesi Global Rare Diseases, Protalix BioT...
05/10/2023 10:05:16